Senti Biosciences is trading 8.6% down at $0.37, with today’s specific catalyst unclear.
- No new company-specific announcement or filing dated August 27, 2026, was identified in available reliable coverage.
- The stock extended recent volatility after declines on August 20 and August 21.
- Quarterly results released August 14 showed an EPS loss of $0.41 versus consensus of -$0.33; broader indexes were mostly higher.